NIKA
NIKA PHARMACEUTICALS, INC
Key Financials
Net Income
$-76398
↑ 20.2%
Operating Income
$-76398
↑ 20.2%
Revenue
$0
NaN%
EPS (Diluted)
$0.00
NaN%
Total Liabilities
$318624.00
↑ 33.2%
Total Assets
$20996.00
↑ 17.1%
Cash & Equivalents
$1889.00
↓ 9.3%
Operating Cash Flow
$-79654.00
↑ 42.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/25/2026 | View on SEC |
| 10-Q | 11/7/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
| 10-Q | 5/13/2025 | View on SEC |
| 144 | 4/16/2025 | View on SEC |
| 10-K | 3/31/2025 | View on SEC |
| 4 | 3/19/2025 | View on SEC |
| 10-Q | 11/12/2024 | View on SEC |
| 10-Q/A | 11/1/2024 | View on SEC |
| 8-K | 10/16/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NIKA |
| Company Name | NIKA PHARMACEUTICALS, INC |
| CIK | 1145604 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | CO |
| Phone | 7023263615 |